AI made execution free. Knowing first is the whole game now.
The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.
Trusted by
Acquiring Company
GE HealthCare
Acquired Company
Sofie Biosciences
ChicagoCulver CityOtherInformation TechnologyBiotechnologyHealth CareMedicalBiotechnologyDescription
GE HealthCare is reportedly in advanced talks to acquire Sofie Biosciences for around USD 1 billion. This acquisition could enhance GE HealthCare's imaging diagnostics product line with radiopharmaceuticals. If finalized, it may reshape the supply chain for diagnostic imaging. The potential announcement is anticipated within the upcoming week.
Fundz sees it the moment GE HealthCare makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
M&A Insights
Based on deal dataFrequently asked
Who acquired Sofie Biosciences?
Sofie Biosciences was acquired by GE HealthCare, based in Chicago. The deal was reported on September 20, 2026. GE HealthCare is publicly traded (GEHC) and operates in Other.
When did GE HealthCare acquire Sofie Biosciences?
GE HealthCare's acquisition of Sofie Biosciences was reported on September 20, 2026. GE HealthCare is reportedly in advanced talks to acquire Sofie Biosciences for around USD 1 billion. This acquisition could enhance GE HealthCare's imaging diagnostics product line with radiopharmaceuticals. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Sofie Biosciences do?
Sofie Biosciences focuses on the development of radiopharmaceuticals for medical imaging. It operates a network that manufactures radioactive materials used in PET scans. The company's product pipeline includes agents for detecting cancers. It is privately held, operating in Biotechnology, and is based in Culver City.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
5 screens from a live account. No signup.